Thousands of women who underwent internal bra breast surgery are now reporting serious complications from surgical mesh placed inside them. Many are pursuing legal action against manufacturers that promoted these products for breast reconstruction, augmentation, revision, or lift procedures, even though no surgical mesh product has been cleared or approved by the FDA specifically for breast surgery.
Breast mesh lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, AlloMax, FlexHD, Strattice, and DuroSorb marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those breast-specific applications had not been adequately studied or cleared by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, implant loss, breast deformity, and the need for additional surgery, many women had no reason to connect their injuries to the mesh product placed inside them.
This page explains the internal bra mesh lawsuit. Our lawyers talk about what the legal claims are, who may be eligible, what complications may qualify, how to identify your mesh product, what evidence matters, and what these cases may be worth.